Author:
High Whitney A.,Ayers Reed A.,Cowper Shawn E.
Reference4 articles.
1. Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis;High;J Am Acad Dermatol,2007
2. Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy;White;Invest Radiol,2006
3. Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review;Idee;Fundam Clin Pharmacol,2006
4. Center for Drug Evaluation and Research. US Food and Drug Administration World Wide Web site. Public health advisory: public health advisory update on magnetic resonance imaging (MRI) contrast agents containing gadolinium and nephrogenic fibrosing dermopathy (December 22, 2006). Available from: URL:http://www.fda.gov/cder/drug/advisory/gadolinium_agents.htm. Accessed December 30, 2006.
Cited by
141 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献